Fragile X syndrome or Martin-Bell syndrome is a syndrome of X-linked mental retardation which results in a spectrum of characteristic physical, intellectual, emotional and behavioural features which range from severe to mild in manifestation.
The syndrome is associated with the expansion of a single trinucleotide gene sequence (CGG) on the X chromosome, and results in a failure to express the FMR1 protein which is required for normal neural development. There are four generally accepted states of the chromosome region involved in Fragile X syndrome which relate to the length of the repeated CGG sequence; Normal (29-31 CGG repeats) (not affected by the syndrome), Premutation (55-200 CGG repeats)(not affected by the syndrome), Full Mutation (more than 200 CGG repeats)(affected), and Intermediate or Gray Zone Alleles (40 - 60 repeats).
Martin and Bell in 1943, described a pedigree of X-linked mental disability, without considering the macroorchidism. In 1969 Chris and Weesam first sighted an unusual "marker X chromosome" in association with mental disability. In 1970 Frederick Hecht coined the term "fragile site"
Renpenning's syndrome is not synonymous with the syndrome. In Renpenning's syndrome, there is no fragile site on the X chromosome. Renpenning's cases have short stature, moderate microcephaly, and neurological (brain) disorders.
Escalante's syndrome is synonymous with the fragile X syndrome. This term has been used in Brazil and other South American countries.
Causes[edit | edit source]
The fragile X syndrome is a genetic disorder caused by mutation of the FMR1 gene on the X chromosome. Mutation at that site is found in 1 out of about every 2000 males and 1 out of about every 259 females. (Incidence of the disease itself is about 1 in every 4000 females.)
Normally, the FMR1 gene contains between 6-55 (29 in Robbins-Kumar pathology textbooks) repeats of the CGG codon (trinucleotide repeats). In people with the fragile X syndrome, the FMR1 allele has over 230-4000 repeats of this codon.
This methylation of the FMR1 locus in chromosome band Xq27.3 is believed to result in constriction of the X chromosome which appears 'fragile' under the microscope at that point, a phenomenon that gave the syndrome its name.
Mutation of the FMR1 gene leads to the transcriptional silencing of the fragile X-mental retardation protein, FMRP. In normal individuals, FMRP is believed to regulate a substantial population of mRNA: FMRP plays important roles in learning and memory, and also appears to be involved in development of axons, formation of synapses, and the wiring and development of neural circuits.
Transmission of the Fragile X[edit | edit source]
The diagram (right) of X-linked recessive inheritance is not entirely inappropriate but it markedly oversimplifies the situation and does not provide a sufficient foundation for genetic counseling about the fragile X syndrome. Technically, fragile X syndrome is an X-linked dominant condition with reduced penetrance.
Because males normally have only one copy of the X chromosome, those males with significant trinucleotide expansion at the FMR1 locus are symptomatic. They are intellectually disabled and may show various physical features of the fragile X syndrome.
Females have two X chromosomes and thus have double the chance of having a working FMR1 allele. Females carrying one X chromosome with an expanded FMR1 gene can have some signs and symptoms of the disorder or be normal. Although the extra X chromosome can serve as a backup, only one X chromosome is active at a time due to X-inactivation.
Males with the fragile X cannot transmit it to any of their sons (since males contribute a Y chromosome, not an X, to their male offspring), but will transmit it to all of their daughters, as males contribute their X to all of their daughters.
Females carrying one copy of the fragile X can transmit it to their sons or daughters; in this case each child has a 50% chance of inheriting the fragile X. Sons who receive the fragile X are at high risk of intellectual disability. Daughters who receive the fragile X may appear normal or they may be intellectually disabled, usually to a lesser degree than boys with the syndrome. The transmission of fragile X often increases with each passing generation. This seemingly anomalous pattern of inheritance is referred to as the Sherman paradox.
Symptoms[edit | edit source]
Aside from intellectual disability, prominent characteristics of the syndrome include an elongated face, large or protruding ears, flat feet, larger testes (macroorchidism), and low muscle tone. Speech may include cluttered speech or nervous speech. Behavioral characteristics may include stereotypic movements (e.g., hand-flapping) and atypical social development, particularly shyness, limited eye contact, memory problems, and difficulty with face encoding.
Some individuals with the fragile X syndrome also meet the diagnostic criteria for autism. Most females who have the syndrome experience symptoms to a lesser degree because of their second X-chromosome, however they can develop just as severe symptoms. While full mutation males tend to present with severe intellectual disability, the symptoms of full mutation females run the gamut of minimally affected to severe intellectual disability, which may explain why females are underdiagnosed relative to males.
In short, similarities between X-linked recessive inheritance and fragile X are:
- Males are predominantly affected;
- Females (mothers) are obligatory carriers (i.e., are conclusively proven to be carriers) if a male child is affected, but not necessarily if female children are affected, as a female child with one fragile and one normal X chromosome may have inherited the fragile chromosome from the father.
A difference is that females may also have clinical symptoms.
Physical phenotype[edit | edit source]
- Prominent ears
- Long face (vertical maxillary excess)
- High-arched palate (related to the above)
- Hyperextensible finger joints
- Double-jointed thumbs
- Flat feet
- Soft skin
- Larger testes in men (macroorchidism)
- Low muscle tone
Social interaction[edit | edit source]
FXS is characterized by social anxiety, including gaze aversion, prolonged time to commence social interaction, and challenges forming peer relationships. Social anxiety in individuals with FXS is related to challenges with face encoding. Face encoding is the ability to recognize a face that one has seen before.
Individuals with FXS show decreased activation in the prefrontal regions of the brain. These regions are associated with social cognition. A child with FXS is likely to have hyperactivity, anxiety, and social deficits. Individuals with fragile X-associated tremor/ataxia syndrome (FXTAS) are likely to experience dementia, mood and/or anxiety disorders. Males with the FMR1 premutation and clinical evidence of FXTAS were found to have increased occurrence of somatization, obsessive–compulsive disorder, interpersonal sensitivity, depression, phobic anxiety and psychoticism.
Females with FXS show a high frequency of avoidant behavior, mood disorder, and habit disorder. Females are significantly more withdrawn and depressed as compared to normal individuals. The size of DNA insertion was related to IQ, severity of attention problems, and withdrawal symptoms. Females with FXS are most vulnerable to social anxiety, social avoidance, withdrawal, and depression, so special attention should be paid.
Mental age is positively correlated and autistic behavior is negatively correlated with sadness in a particular study. The results shows that there are different behavioral profiles for young children then there are for older aged children which implies that temperament and problem behaviors are not rooted in early temperament.
Working memory[edit | edit source]
From their 40s onward, males with FXS begin developing progressively more severe problems in performing tasks that require the central executive of working memory. Working memory involves the temporary storage of information 'in mind', while processing the same or other information. Phonological memory (or verbal working memory) deteriorates with age in males, while visual-spatial memory is not found to be directly related to age. Males often experience an impairment in the functioning of the phonological loop. The CGG length is significantly correlated with central executive and the visual–spatial memory through regression analysis. However, in a premutation individual, CGG length is only significantly correlated with the central executive, not with either phonological memory or visual–spatial memory.
Intellectual development[edit | edit source]
Current evidence shows that individuals with premutation have difficulties with mathematics, anxiety, attention, and/or executive functions. Premutation is the stage where the CGG sequence in the FMR-1 gene expands to contain between 54 and 230 repeats. There is also a decrease in measures of executive cognitive functioning, working memory and information processing speed. The relative weaknesses observed in performance IQ can be partly attributed to slowed motor performance as a result of intention tremor. Children with FXS have an intellectual learning rate which is 2.2 times slower than unaffected children.
There is overlap of behavioral and clinical symptomology between autism and FXS. The commonalities include social and communication skills, though the degree to which these two syndromes share the processes and stages of development and medical causes for the disease (etiology) is not known. Research has shown that phenotype ‘commonalities’ reflected different developmental pathways that diverge over time and across syndromes.
Using this information will permit early and specialized interventions. These earlier interventions will allow for optimal development and show educational, clinical, and adaptive benefits in the patient. When both autism and FXS are present a severe language deficit and lower IQ is observed as compared to children with only FXS.
Hypersensitivity and repetitive behavior[edit | edit source]
Children with fragile X have very short attention spans, are hyperactive, and show hypersensitivity to visual, auditory, tactile, and olfactory stimuli. These children have difficulty in large crowds due to the loud noises and this can lead to tantrums due to hyperarousal. Children with FXS pull away from light touch and can find textures of materials to be irritating. Transitions from one location to another can be difficult for children with FXS. Behavioral therapy can be used to improve the child’s sensitivity in some cases.
Perseveration is a common communicative and behavioral characteristic in FXS. Children with FXS may repeat a certain ordinary activity over and over. In speech, the trend is not only in repeating the same phrase but also talking about the same subject continually. Cluttered speech and self-talk are commonly seen. Self-talk includes talking with oneself using different tones and pitches.
Visual orientation[edit | edit source]
Eye problems have not been found to develop in accordance with mental age in individuals with fragile X. But patients with the syndrome have showed delayed voluntary orienting. The group differences in reflexive orienting between individuals with Down and fragile X syndrome at the low mental age level reinforce the practice of separating etiologies and highlight the contribution of basic attentional processes in the study of people with mental retardation.
Ophthalmologic problems include strabismus (lazy eye). This requires early identification to avoid amblyopia. Surgery and/or patching are usually necessary to treat strabismus if diagnosed early. Refractive errors in patients with fragile X are also common.
Diagnosis[edit | edit source]
Fragile X syndrome was originally diagnosed by culturing cells in a folate deficient medium and then assessing the cultures for X-chromosome breakage by cytogenetic analysis of the long arm of the X chromosome. This technique proved unreliable for both diagnosis and carrier testing.
Not everyone with fragile X syndrome has the same signs and symptoms. Even affected people in the same family don’t show the same symptoms. The signs and symptoms fall into six categories:
- Intelligence and learning
- Social and emotional
- Speech and language
- Disorders commonly associated or sharing features with Fragile X
Treatment and current research[edit | edit source]
Recent studies have focused on a number of critical areas. The role of FMRP's RNA partners, many of which have now been validated through in vitro assays, is of primary importance. Also being examined is the function the various domains of FMRP, an RNA-binding protein, which is still relatively unknown. One hypothesis is that many symptoms are caused by unchecked activation of mGluR5, a metabotropic glutamate receptor, which was found in a 2007 study to contribute significantly to the pathogenesis of the disease; this suggests that mGluR5 blockers could be used to treat fragile X syndrome.
Although several medications have been proposed to treat fragile X syndrome, none of them are supported by good evidence. While there is no current cure for the syndrome, there is hope that further understanding of its underlying causes would lead to new therapies. Currently, the syndrome can be treated through behavioral therapy, special education, and when necessary, treatment of physical abnormalities. Persons with the fragile X syndrome in their family histories are advised to seek genetic counseling to assess the likelihood of having children who are affected, and how severe any impairments may be in affected descendants.
See also[edit | edit source]
References[edit | edit source]
- Sherman, S. (2002). "Epidemiology". Chapter 3 in Fragile X Syndrome, Diagnosis Treatment and Research. Ed. Hagerman, R. J. & Hagerman, P.J. (3rd Edition). Johns Hopkins University Press: Baltimore.
- Martin, J. P. & Bell, J. "A pedigree of mental defect showing sex-linkage". Journal of neurology, neurosurgery, and psychiatry (J. Neurol. Psychiat.). BMJ Publishing Group, London 6.1943, 154-157. ISSN 0022-3050
- Lubs, H. (1969) "A marker X chromosome". Am Hum Genet 21: 231.
- Nolin SL, Brown WT, Glicksman A, et al. (2003). Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am. J. Hum. Genet. 72 (2): 454–64.
- Bassell GJ, Warren ST (2008). Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60 (2): 201–14.
- Signs of Fragile-X Syndrome - WrongDiagnosis.com
- Goldstein, Sam, and Cecil R. Reynolds. Handbook of neurodevelopmental and genetic disorders in children. Guilford P, 1999.
- Holsen, Laura M., Kim M. Dalton, Tom Johnstone, and Richard J. Davidson. "Prefrontal social cognition network dysfunction underlying face encoding and social anxiety in fragile X syndrome." NeuroImage 43 (Nov 2008): 592-604. <http://web.ebscohost.com.ezproxy2.library.arizona.edu/ehost/detail?vid=8&hid=12&sid=79f62b60-f868-4405-9210-0da8e255af9e%40SRCSM1>.
- Bourgeois, James A., Jennifer B. Cogswell, David Hessel, et al. "Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome." General Hospital Psychiatry 29 (July 2007): 349-56. <http://web.ebscohost.com.ezproxy2.library.arizona.edu/ehost/detail?vid=7&hid=51&sid=86abd748-beb6-4194-a29f-f86417fed1d3%40sessionmgr9>
- Shanahan, M., J. Roberts, D. Hatton, J. Reznick, and H. Goldsmith. "Early temperament and negative reactivity in boys with fragile X syndrome." Journal of Intellectual Disability Research 52 (Oct 2008): 842-54. <http://web.ebscohost.com.ezproxy2.library.arizona.edu/ehost/detail?vid=4&hid=114&sid=07584871-10b0-4049-810c-696c0d6a2b43%40sessionmgr107>.
- Cornish, Kim, Cary S. Kogan, Lexin Li, Jeremy Turk, et al. "Lifespan changes in working memory in fragile X premutation males." Brain and Cognition 69 (Apr 2009): 551-58. <http://web.ebscohost.com.ezproxy2.library.arizona.edu/ehost/detail?vid=4&hid=4&sid=b31c83d6-be19-483e-81b2-757ff99e731a%40SRCSM1>.
- Hall, Scott S., David D. Burns, and Amy A. Lightbody. "Longitudinal Changes in Intellectual Development in Children with Fragile X Syndrome." Journal of Abnormal Child Psychology 36 (Aug 2008): 927-39. <http://web.ebscohost.com.ezproxy2.library.arizona.edu/ehost/detail?vid=9&hid=12&sid=79f62b60-f868-4405-9210-0da8e255af9e%40SRCSM1>.
- Cornish, Kim, Jeremy Turk, and Andrew Levitas. "Fragile X Syndrome and Autism: Common Developmental Pathways?" Current Pediatric Reviews 3 (2007): 3-4. <http://web.ebscohost.com.ezproxy2.library.arizona.edu/ehost/pdf?vid=5&hid=5&sid=a9b2e615-3413-4d58-a0c4-b26d56911bbb%40sessionmgr2>.
- Hagerman, Randi J., and Paul J. Hagerman. Fragile X syndrome: diagnosis, treatment, and research. 3, illustrated ed. Baltimore, MD: JHU P, 2002.
- Dölen G, Osterweil E, Rao BS et al. (2007). Correction of fragile X syndrome in mice. Neuron 56 (6): 955–62.
- includeonly>Highfield R. "Fragile X study offers hope for autism treatment", Daily Telegraph, 2007-12-19. Retrieved on 2007-12-22.
- Rueda JR, Ballesteros J, Tejada MI (2009). Systematic review of pharmacological treatments in fragile X syndrome. BMC Neurol 9: 53.
- Hagerman RJ, Berry-Kravis E, Kaufmann WE et al. (2009). Advances in the treatment of fragile X syndrome. Pediatrics 123 (1): 378–90.
[edit | edit source]
- CDC’s National Center on Birth Defects and Developmental Disabilities
- FraXA.org - The Fragile X Research Foundation
- http://www.fragilex.org.uk/index.asp - The United Kingdom National Fragile X charity
- FragileX.org - The National Fragile X Foundation (US) - Support, Awareness, Education, Research and Advocacy since 1984
- The Colorado Fragile X Consortium
- Stanford.edu - 'Trinucleotide Repeat Disorders Part 9: Non-Polyglutamine Diseases: Descriptions of other diseases that involve codon repeat expansions' (September 18, 2002)
- Genetics of Fragile X Syndrome
- Gene Reviews
Pervasive developmental disorders / Autism spectrum